Molecular Targeted Therapy Global Market Report 2025
상품코드:1769662
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
분자 표적 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간 동안의 성장 전망은 암 연구에 대한 투자 증가, 표적 면역 요법에 대한 수요 증가, 정밀 의학 분야의 임상 시험 활동 확대, 동반 진단 사용 증가, 신흥 시장의 의료 서비스 접근성 개선에 의해 촉진될 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 유전체학의 발전, 의약품 전달 시스템의 혁신, R&D에 대한 자금 지원 증가, 분자 진단의 발전, 치료법 발견에 AI 기술의 통합 등이 있습니다.
맞춤형 의약품의 부상은 앞으로 분자 표적 치료 시장의 성장을 촉진할 것으로 예상됩니다. 맞춤형 의약품은 개인의 유전적 프로필, 생활 방식 및 환경적 요인에 따라 치료 및 예방을 맞춤화하는 의료 접근 방식입니다. 이 접근 방식은 유전 정보의 이용 가능성이 높아짐에 따라 주목을 받고 있으며, 이를 통해 개별 게놈에 맞는 치료를 통해 효능을 높이고 부작용을 줄일 수 있습니다. 맞춤형 의약품은 환자의 종양에서 특정 유전자 변이 또는 바이오마커를 분석하여 이러한 이상을 직접 표적으로 하는 치료법을 선택할 수 있도록 지원함으로써 분자 표적 치료법을 뒷받침합니다. 이를 통해 치료의 정확성이 향상되고 건강한 조직에 대한 손상이 최소화됩니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 병원 및 의료 기관인 Personalized Medicine Coalition은 FDA가 2023년에 희귀 질환 환자를 위한 16개의 새로운 맞춤형 치료법을 승인했다고 밝혔습니다. 이는 2022년의 6개에서 증가한 수치입니다. 따라서 맞춤형 의학의 부상은 분자 표적 치료 시장의 성장을 촉진하고 있습니다.
분자 표적 치료 시장에서 사업을 전개하는 주요 기업들은 다양한 암과 만성 질환 환자의 치료 결과를 개선하기 위해 소분자 억제제와 같은 고급 제품 개발에 집중하고 있습니다. 소분자 억제제는 세포에 침투하여 질병의 진행을 촉진하는 특정 단백질을 억제할 수 있는 작은 화합물입니다. 예를 들어, 2025년 1월, 미국 제약 회사인 Amgen Inc.는 미국 정부 기관인 미국 식품의약국(FDA)의 승인을 받은 Vectibix(파니투무맙)와 함께 Lumakras(소토라시브)를 출시했습니다. 이 치료법은 FDA 승인 검사를 통해 확인된 KRAS G12C 변이형 전이성 대장암을 가진 성인 환자로, 이전에 플루오로피리미딘, 옥살리플라틴, 이리노테칸 기반 화학요법을 받은 환자를 대상으로 합니다. 이 승인은 Phase 3 CodeBreaK 300 임상 시험 결과를 기반으로 하며, 이 조합이 표준 치료 대비 무진행 생존 기간을 두 배 이상 연장했음을 입증했습니다. 이는 이 화학요법 저항성 환자 집단에서 이러한 결과를 달성한 첫 번째 표적 치료제입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 분자 표적 치료: PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 분자 표적 치료 시장 : 성장률 분석
세계의 분자 표적 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 분자 표적 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 분자 표적 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 분자 표적 치료 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단일클론항체
저분자 억제제
유전자 치료
세포요법
세계의 분자 표적 치료 시장 : 투여 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사제
국소
정맥내
세계의 분자 표적 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
폐암
유방암
대장암
백혈병
기타 용도
세계의 분자 표적 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
연구실
진단센터
세계의 분자 표적 치료 시장 : 단일클론항체 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
노출형 단일클론항체
결합 단일클론항체
이중특이성 단일클론항체
세계의 분자 표적 치료 시장 : 저분자 억제제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
티로신 키나아제 억제제(TKI)
프로테아좀 억제제
폴리아데노신 디인산(ADP) 리보스 폴리머라제(PARP) 억제제
라파마이신의 기구 표적(mTOR) 억제제
세계의 분자 표적 치료 시장 : 유전자 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
바이러스 벡터를 이용한 유전자 치료
비바이러스 벡터 기반 유전자 치료
유전자 편집
세계의 분자 표적 치료 시장 : 세포 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
키메라 항원 수용체 T 세포 요법
T 세포 수용체(TCR) 요법
종양 침윤 림프구(TIL) 요법
수지상세포요법
제7장 지역별, 국가별 분석
세계의 분자 표적 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 분자 표적 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
분자 표적 치료 시장 : 경쟁 구도
분자 표적 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
AstraZeneca PLC
Amgen Inc.
Regeneron Pharmaceuticals
Vertex Pharmaceuticals Incorporated
Novartis AG
Incyte Corporation
Exelixis Inc.
IDEAYA Biosciences Inc.
Prelude Therapeutics Incorporated
Gamida Cell Ltd.
Adaptimmune Therapeutics plc
Engine Biosciences Pte. Ltd.
Krystal Biotech Inc.
Sotio Biotech as
Cybrexa Therapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
분자 표적 치료 시장(2029년) : 새로운 기회를 제공하는 국가
분자 표적 치료 시장(2029년) : 새로운 기회를 제공하는 부문
분자 표적 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Molecular targeted therapy is an advanced form of cancer treatment that works by blocking the growth and spread of cancer cells through interference with specific molecules involved in tumor development. This therapy is tailored to the genetic and molecular profile of a patient's tumor, aiming to increase treatment effectiveness while reducing damage to healthy cells. By focusing on cancer-specific pathways, it provides a more precise and less toxic alternative compared to traditional therapies.
The primary types of molecular targeted therapy include monoclonal antibodies, small-molecule inhibitors, gene therapy, and cell therapy. Monoclonal antibodies are specially engineered proteins that accurately target and eliminate cancer cells while sparing healthy tissue. This therapy is delivered through various methods such as oral, injectable, topical, and intravenous routes and is applied in the treatment of several cancers, including lung, breast, colorectal cancers, leukemia, and others. It is utilized by multiple end-users such as hospitals, clinics, research laboratories, and diagnostic centers.
The molecular targeted therapy market research report is one of a series of new reports from The Business Research Company that provides molecular targeted therapy market statistics, including the molecular targeted therapy industry global market size, regional shares, competitors with the molecular targeted therapy market share, detailed molecular targeted therapy market segments, market trends, opportunities, and any further data you may need to thrive in the molecular targeted therapy industry. This molecular targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The molecular targeted therapy market size has grown strongly in recent years. It will grow from $65.78 billion in 2024 to $71.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth observed during the historic period was driven by factors such as the rising prevalence of chronic diseases, increasing demand for personalized medicine, greater use of biomarkers in drug development, wider adoption of monoclonal antibodies, and more oncology therapy approvals.
The molecular targeted therapy market size is expected to see strong growth in the next few years. It will grow to $99.40 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The projected growth in the forecast period is expected to be fueled by increased investment in cancer research, growing demand for targeted immunotherapies, expansion of clinical trial activities in precision medicine, rising use of companion diagnostics, and improved healthcare access in emerging markets. Key trends anticipated during the forecast period include advancements in genomics, innovations in drug delivery systems, increased funding for R&D, progress in molecular diagnostics, and the integration of AI technology in therapy discovery.
The rise of personalized medicine is expected to propel the growth of the molecular targeted therapy market going forward. Personalized medicine is a healthcare approach that customizes treatment and prevention based on an individual's genetic profile, lifestyle, and environmental factors. This approach is gaining traction due to the increasing availability of genetic data, which enables treatments tailored to individual genomes for improved efficacy and reduced side effects. Personalized medicine supports molecular targeted therapy by analyzing a patient's tumor for specific genetic mutations or biomarkers, allowing for the selection of therapies that directly target those abnormalities. This enhances treatment precision and minimizes harm to healthy tissues. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the rise of personalized medicine is driving the growth of the molecular targeted therapy market.
Major companies operating in the molecular targeted therapy market are focusing on developing advanced products such as small molecule inhibitors to improve patient outcomes in various cancers and chronic diseases. Small molecule inhibitors are tiny compounds capable of penetrating cells and inhibiting specific proteins that drive disease progression. For example, in January 2025, Amgen Inc., a US-based pharmaceutical company, introduced Lumakras (sotorasib) in combination with Vectibix (panitumumab), which received approval from the US Food and Drug Administration (FDA), a US-based government organization. This therapy is intended for adult patients with KRAS G12C-mutated metastatic colorectal cancer who have previously undergone fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, as confirmed by an FDA-approved test. The approval is based on the Phase 3 CodeBreaK 300 trial, which demonstrated that the combination more than doubled progression-free survival compared to the standard of care, marking the first targeted therapy to achieve such results in this chemorefractory patient group.
In December 2023, Pfizer Inc., a US-based pharmaceutical company, acquired Seagen Inc. for approximately $43 billion. Through this acquisition, Pfizer aims to bolster its oncology portfolio and expedite the development of innovative cancer therapies by leveraging Seagen's expertise in antibody-drug conjugate (ADC) technology. Seagen Inc. is a US-based company specializing in the development of monoclonal antibody-based therapies for cancer treatment.
North America was the largest region in the molecular targeted therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in molecular targeted therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the molecular targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The molecular targeted therapy market consists of sales of targeted cancer drugs, kinase inhibitors, hormone therapies, and companion diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Molecular Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on molecular targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for molecular targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The molecular targeted therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapy Type: Monoclonal Antibodies; Small Molecule Inhibitors; Gene Therapy; Cell Therapy
2) By Mode Of Administration: Oral; Injectable; Topical; Intravenous
3) By Application: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Other Applications
4) By End-User: Hospitals; Clinics; Research Laboratories; Diagnostic Centers
3. Molecular Targeted Therapy Market Trends And Strategies
4. Molecular Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Molecular Targeted Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Molecular Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Molecular Targeted Therapy Market Growth Rate Analysis
5.4. Global Molecular Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Molecular Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Molecular Targeted Therapy Total Addressable Market (TAM)
6. Molecular Targeted Therapy Market Segmentation
6.1. Global Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Small Molecule Inhibitors
Gene Therapy
Cell Therapy
6.2. Global Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
Intravenous
6.3. Global Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Other Applications
6.4. Global Molecular Targeted Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Laboratories
Diagnostic Centers
6.5. Global Molecular Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Naked Monoclonal Antibodies
Conjugated Monoclonal Antibodies
Bispecific Monoclonal Antibodies
6.6. Global Molecular Targeted Therapy Market, Sub-Segmentation Of Small Molecule Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.7. Global Molecular Targeted Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Vector-Based Gene Therapy
Non-Viral Vector-Based Gene Therapy
Genome Editing
6.8. Global Molecular Targeted Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chimeric Antigen Receptor T-Cell Therapy
T-Cell Receptor (TCR) Therapy
Tumor-Infiltrating Lymphocytes (TILs) Therapy
Dendritic Cell Therapy
7. Molecular Targeted Therapy Market Regional And Country Analysis
7.1. Global Molecular Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Molecular Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Molecular Targeted Therapy Market
9.1. China Molecular Targeted Therapy Market Overview
9.2. China Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Molecular Targeted Therapy Market
10.1. India Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Molecular Targeted Therapy Market
11.1. Japan Molecular Targeted Therapy Market Overview
11.2. Japan Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Molecular Targeted Therapy Market
12.1. Australia Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Molecular Targeted Therapy Market
13.1. Indonesia Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Molecular Targeted Therapy Market
14.1. South Korea Molecular Targeted Therapy Market Overview
14.2. South Korea Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Molecular Targeted Therapy Market
15.1. Western Europe Molecular Targeted Therapy Market Overview
15.2. Western Europe Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Molecular Targeted Therapy Market
16.1. UK Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Molecular Targeted Therapy Market
17.1. Germany Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Molecular Targeted Therapy Market
18.1. France Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Molecular Targeted Therapy Market
19.1. Italy Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Molecular Targeted Therapy Market
20.1. Spain Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Molecular Targeted Therapy Market
21.1. Eastern Europe Molecular Targeted Therapy Market Overview
21.2. Eastern Europe Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Molecular Targeted Therapy Market
22.1. Russia Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Molecular Targeted Therapy Market
23.1. North America Molecular Targeted Therapy Market Overview
23.2. North America Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Molecular Targeted Therapy Market
24.1. USA Molecular Targeted Therapy Market Overview
24.2. USA Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Molecular Targeted Therapy Market
26.1. South America Molecular Targeted Therapy Market Overview
26.2. South America Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Molecular Targeted Therapy Market
27.1. Brazil Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Molecular Targeted Therapy Market
28.1. Middle East Molecular Targeted Therapy Market Overview
28.2. Middle East Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Molecular Targeted Therapy Market
29.1. Africa Molecular Targeted Therapy Market Overview
29.2. Africa Molecular Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Molecular Targeted Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Molecular Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Molecular Targeted Therapy Market Competitive Landscape And Company Profiles
